Research Focus

Former Employee. Graduate Staff; Fellow

Recent additions – View all

1. Oncolytic viral gene therapy for prostate cancer using two attenuated, replication-competent, genetically engineered herpes simplex viruses

   Journal Article

   Cozzi, P. J.; Burke, P. B.; Bhargava, A.; Heston, W. D. W.; Huryk, B.; Scardino, P. T.; Fong, Y.
   Prostate (2002)

   Fulltext@MSK | Save
2. Intravesical oncolytic viral therapy using attenuated, replication-competent herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model

   Journal Article

   Cozzi, P. J.; Malhotra, S.; McAuliffe, P.; Kooby, D. A.; Federoff, H. J.; Huryk, B.; Johnson, P.; Scardino, P. T.; Heston, W. D.; Fong, Y.
   FASEB Journal (2001)

   Fulltext@MSK | Save
3. Oncolytic viral therapy for bladder cancer using a multimutated herpes simplex virus type-1 (g-207)

   Meeting Abstract

   Cozzi, P.; Kooby, D.; Federoff, H.; Huryk, B.; Heston, W.; Fong, Y.
   Proceedings of the American Association for Cancer Research Annual Meeting (1999)

   Fulltext@MSK | Save